Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 143
Selected: 0
NCT IDTitle
NCT07013461International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer
NCT01228045A Study of Trastuzumab in Combination With TS-ONE & Cisplatin in First-line Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer
NCT04118114Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors
NCT04025515Molecular Profiling Project
NCT01029418AZD6244 and Sorafenib in Advanced Hepatocellular Carcinoma
NCT01540110Study of Neoadjuvant Docetaxel and Cyclophosphamide in Locally Advanced or Node Positive Primary Breast Cancer With Companion Pharmacokinetic and Pharmacogenomic Analyses
NCT0499518518F-FMISO PET Guided Dose Escalation in Nasopharyngeal Carcinoma - a Feasibility and Planning Study
NCT06587295Intramuscular ACM-CpG Monotherapy in Patients With Advanced/Metastatic Solid Tumors With Prior Response to Immunotherapy Alone or in Combination With Chemotherapy
NCT07428356Histotripsy for Ablation of Liver Tumours in Asia
NCT07234357Sensory Enrichment Using Aromatherapy for Neurobehavioral and Psychological Symptoms in Early Dementia
NCT06244953Timely Interventions to Enable and Reach Patients With Heart Failure, and Their Caregivers With Palliative Care
NCT04224480Longitudinal Immune-phenotyping of HCC Following MK-3475
NCT02143388Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Randomized Control Clinical Trial
NCT07733973Effectiveness, Acceptability and Feasibility of a Communication and Care Coordinator (CCC) Model in Facilitating Serious Illness Communication (SIC) and Care in Patients With Cancer
NCT03093831Phase II Study of Ibrutinib in Patients With Relapsed or Refractory Marginal Zone Lymphoma
NCT01341834Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors
NCT03233360Hepatocellular Carcinoma Registry in Asia: The INSIGHT Registry
NCT06418412A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLC
NCT01765686Comparing Harmonic Ultrasonic Scalpel to Small Jaw Bipolar Device in Thyroid Surgery
NCT05355558A Novel Functional Imaging Technique With FLT-PET/MRI For Staging, Response Assessment and Radiation Treatment Planning in Cervix Cancer
NCT07583979Electroacupuncture for Cognitive Toxicity in Cancer Survivors: Assessing Implementation, Cost, and Effectiveness for Integration
NCT03100006Phase Ib/IIa Trial to Evaluate Oregovomab and Nivolumab in Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin
NCT00589186Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer
NCT03200730A Novel Family Dignity Intervention (FDI) for Asian Palliative Care
NCT00702481Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer
NCT05581979PSMA-PET Imaging of Salivary Gland Tumours and Other Rare Cancers
NCT02801734Enhancing Quality of Life in Patients (EQUIP) Intervention for Patients With Advanced Lung Cancer
NCT02931864Effects of an e-Home Based Symptom Management and Mindfulness Training Programme on QoL in Breast Cancer Survivors
NCT00003576Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During Surgery
NCT04738708Telegenetics or In-Person Genetic Counselling
NCT04961632Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376
NCT03212807Study Of Durvalumab and Lenalidomide In R/R EBV Associated DLBCL Subtypes, Primary CNS And Testicular DLBCL
NCT04014309Accessible Cancer Care to Enable Support for Survivors Programme
NCT07133269Care Coach-led Integrated Palliative Surgical Oncology and Rehabilitation Care Model for Advanced Cancer Patients
NCT03330509Effectiveness of the Supportive and Palliative Care Review Kit (SPARK) for Cancer Patients in the Acute Hospital
NCT07241715Conversion Surgery for Gastric Cancer With Peritoneal Metastases (CONVERGENCE)
NCT04946968Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers
NCT00565708Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers
NCT04961489Impact of Measures Taken to Contain COVID-19 on Hospital Surgical Care Services and Clinical Outcomes
NCT05211882ENABLE (Educate, Nurture, Advise, Before Life Ends) Intervention for Heart Failure (HF) Patients and Their Caregivers in Singapore
NCT01716689Clinical Study of Metronomic Oral Cyclophosphamide in Patients With Advanced Sarcomas
NCT07209501Evaluating the Feasibility and Acceptability of Inhalation Aromatherapy for Patients Undergoing Autologous Haematopoietic Stem Cell Transplant (HSCT)
NCT05148572Prospective Cohort Study of Changes in Circulatory MicroRNA of Resected Hepatocellular Carcinoma
NCT01100801A Study of Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients
NCT05929885Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients
NCT04027647Phase 2 Study of Dacomitinib in NSCLC
NCT02720926Study of TKI 258 in Combination With Xeloda and Oxaliplatin in Advanced Colorectal and Gastric Cancer
NCT06766058Evaluating the Effectiveness of Aromatherapy for Alleviating Distress in Breast Cancer Patients Before Radiotherapy.
NCT02420067Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients
NCT01309607Study of Preoperative Weekly Paclitaxel and Carboplatin With Lapatinib (Tykerb®) in Patients With ErbB2-Positive Stage I-III Breast Cancer